Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...

ExEm Foam is indicated for sonohysterosalpingography to assess fallopian tube patency in women with known or suspected infertility. ExEm ® Foam ([air polymer-type A] intrauterine foam; ExEm Foam Inc), ...

In the field of cancer medicine, the prevailing wisdom is that early detection and diagnosis saves lives. Catching cancer at earlier stages generally improves patient outcomes and increases chances of ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda. The U.S. Food and Drug Administration (FDA) has ...

Fallopian tube cancer starts in the fallopian tubes, which connect a woman's ovaries to their uterus. Each month, an ovary releases one egg into the fallopian tube. The egg either gets fertilized by ...

A new study creates a detailed 'atlas' of the various cell types and their gene activities within the highly specialized fallopian tube, paving the way for new research into infertility and other ...

A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The ...